Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Int J Tuberc Lung Dis. 2011 Feb;15(2):179–iii.

Table 2.

Characteristics of TB patients associated with QFT-G results

QFT-G
positive
QFT-G
negative
P value ORadj (95%CI) Variable(s) adjusted
for in final model
(n=119) (n=50)

Sociodemographics n(row %)* n(row %)*


Country of enrollment 0.16
   Mexico-Tamaulipas 88 (67.7) 42 (32.3)
   US-Texas 31 (79.5) 8 (20.5)
BCG vaccination 0.06 Age, COE
   Yes 75 (65.8) 39 (34.2) 0.4 (0.2, 1.2)
   No 32 (82.1) 7 (17.9) 1
White Hispanic 118 (70.2) 50 (29.8) 0.51
Age 0.58
   20–35 42 (67.7) 20 (32.3)
   36–59 58 (69.9) 25 (30.1)
   60+ 19 (79.2) 5 (20.8)
Gender 0.24
   Male 77 (67.5) 37 (32.5)
   Female 42 (76.4) 13 (23.6)

TB characteristics at enrollment

Smear result 0.56
   Positive 107 (69.5) 47 (30.5)
   Negative 11 (78.6) 3 (21.4)
Culture performed 0.049 COE
   Yes 65 (77.4) 19 (22.6) 1.8 (0.8, 3.8)
   No 54 (63.5) 31 (36.5) 1
Days of anti-TB treatment 0.18
   None 33 (78.6) 9 (21.4)
   Between 1 and 7 86 (67.7) 41(32.3)

Diabetes and body-mass index

Diabetes 0.01 Age, BMI
   Yes 59 (80.8) 14 (19.2) 2.4 (1.1, 5.0)
   No 60 (62.5) 36 (37.5) 1
HbA1c ≥ 6.5% 0.007 Age, BMI
   Yes 47 (83.9) 9 (16.1) 2.7 (1.2, 6.2)†
   No 72 (63.7) 41 (36.3) 1
Hyperglycemia 0.003 BMI, COE
   Yes 41 (87.2) 6 (12.8) 3.7 (1.4, 9.7)
   No 78 (63.9) 44 (36.1) 1
Body mass index 0.049
   Underweight 19 (57.6) 14 (42.4) 0.5 (0.2, 1.1)
   Normal weight 65 (69.1) 29 (30.9) 1 None
   Overweight or obese 35 (83.3) 7 (16.7) 2.6 (1.0, 6.2)

Risks for TB other than diabetes

Alcohol abuse 0.28
   Yes 20 (62.5) 12 (37.5)
   No 99 (72.3) 38 (27.7)
Drug abuse 0.83
   Yes 28 (71.8) 11 (28.2)
   No 91 (70) 39 (30)
History of incarceration 1.00
   Yes 7 (70) 3 (30)
   No 112 (70.4) 47 (29.6)
HIV positive 1.00
   Yes 4 (80) 1 (20)
   No 115 (70.1) 49 (29.9)
*

Due to missing demographic information (BCG n=153; Smear n=168), totals for these variables will not sum to the total sample; Variables initially controlled for in multivariate models prior to backward elimination included all the variable under sociodemographics, risks for TB other than diabetes, and body-mass index; COE, country of enrollment; QTF-G, QuantiFERON®-TB Gold